News

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market …

Read the full story

June e-Newsletter | NBCA Summer News & Information

Summer is upon us and the time for hitting the road for the beach, family vacations, and other …

Read the full story

Clinical Trial: Cancer and Blood Clots

Cancer patients can be at much higher risk for blood clots.  The National Blood Clot Alliance …

Read the full story

May e-Newsletter | Celebrate National Women’s Health Week

This May, our e-Newsletter is packed with exciting information. In recognition of Women’s …

Read the full story

National Women’s Health Week 2017

A Movement to Raise Awareness about Birth Control and Blood Clot Risks Stand with the National …

Read the full story

100 Days of Blood Clot Awareness

Postscript July 2017 The National Blood Clot Alliance (NBCA) extends its appreciation to …

Read the full story

New Study Enrolling Patients

Researchers are seeking to enroll patients in a new clinical study. The PEPPER trial is …

Read the full story

Caregiver Resources

The National Blood Clot Alliance (NBCA) has partnered with ProPatient.com, a provider of …

Read the full story

March e-Newsletter | Blood Clot Awareness Month

This March, our e-Newsletter is packed with exciting information in recognition of Blood Clot …

Read the full story

Blood Clot Awareness Month 2017: “Know More, Share More”

Know More, Share More During Blood Clot Awareness Month 2017 March is Blood Clot Awareness …

Read the full story

Current News

Erin VanDyke Appointed as VP of NBCA’s VTE Centers of Excellence™

The National Blood Clot Alliance, the nation’s leading patient advocacy organization dedicated to advancing the prevention, early diagnosis, and successful …

Introducing the NBCA Advocacy Institute

To put an end to the 100,000 deaths each year to blood clots, the National Blood Clot Alliance is accelerating…